Content area

|
|

Benzodiazepiner er fortsat førstevalg til behandling af alkoholabstinenssymptomer

Forfatter(e)
Gro Askgaard1, Anton Pottegård2 & Anders Fink-Jensen3 1) Hepatologisk Klinik, Rigshospitalet 2) Afdeling for Klinisk Farmakologi og Farmaci, Institut for Sundhedstjenesteforskning, Syddansk Universitet 3) Psykiatrisk Center København, Region Hovedstadens Psykiatri Ugeskr Læger 2017;179:V07160465
Reference: 
Ugeskr Læger 2017;179:V07160465
Blad nummer: 
Sidetal: 
2-5
Benzodiazepines should still be first-line treatment for alcohol withdrawal
In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzo­diazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Pedram Kazemi-Esfarjani | 28/11
2 kommentarer
af David McWhan | 27/11
4 kommentarer
af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer
af Jan Nielsen | 23/11
1 Kommentar
af Toke Seierøe Barfod | 23/11
2 kommentarer
af Thorkild I.A. Sørensen | 20/11
1 Kommentar
af Kim Varming | 20/11
1 Kommentar
af Niels Holmark Andersen | 20/11
1 Kommentar